SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $736,000 | -44.6% | 14,632 | -34.1% | 0.00% | -40.0% |
| Q2 2018 | $1,328,000 | -13.0% | 22,205 | -33.4% | 0.01% | -16.7% |
| Q1 2018 | $1,526,000 | +14.9% | 33,331 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $1,328,000 | +8.0% | 33,331 | +8.4% | 0.01% | 0.0% |
| Q3 2017 | $1,230,000 | +11.6% | 30,760 | +20.3% | 0.01% | 0.0% |
| Q2 2017 | $1,102,000 | +2961.1% | 25,577 | +2104.9% | 0.01% | – |
| Q1 2017 | $36,000 | – | 1,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |